CytoDyn Updates
- Home
- United States
- Vancouver, WA
- CytoDyn Updates
Leronlimab (PRO 140), a CCR5 antagonist, is a viral-entry inhibitor currently being tested to treat HIV, cancer, GvHD, and now, COVID-19.
Address
Vancouver, WA
Website
Alerts
Be the first to know and let us send you an email when CytoDyn Updates posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Business
Send a message to CytoDyn Updates:
